title: The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo.
abstract: Hypertrophic scars (HTS) and keloids are challenging problems. Their pathogenesis results from an overproduction of fibroblasts and excessive deposition of collagen. Studies suggest a possible anti-scarring effect of basic fibroblast growth factor (bFGF) during wound healing, but the precise mechanisms of bFGF are still unclear. In view of this, we investigated the therapeutic effects of bFGF on HTS animal model as well as human scar fibroblasts (HSF) model. We show that bFGF promoted wound healing and reduced the area of flattened non-pathological scars in rat skin wounds and HTS in the rabbit ear. We provide evidence of a new therapeutic strategy: bFGF administration for the treatment of HTS. The scar elevation index (SEI) and epidermal thickness index (ETI) was also significantly reduced. Histological reveal that bFGF exhibited significant amelioration of the collagen tissue. bFGF regulated extracellular matrix (ECM) synthesis and degradation via interference in the collagen distribution, the α-smooth muscle actin (α-SMA) and transforming growth factor-1 (TGF-β1) expression. In addition, bFGF reduced scarring and promoted wound healing by inhibiting TGFβ1/SMAD-dependent pathway. The levels of fibronectin (FN), tissue inhibitor of metalloproteinase-1 (TIMP-1) collagen I, and collagen III were evidently decreased, and matrix metalloproteinase-1 (MMP-1) and apoptosis cells were markedly increased. These results suggest that bFGF possesses favorable therapeutic effects on hypertrophic scars in vitro and in vivo, which may be an effective cure for human hypertrophic scars.
authors.affiliation: School of Pharmacy, Key Laboratory of Biotechnology and Pharmaceutical Engineering, Wenzhou Medical College, Wenzhou, PR China.
authors.forename: Hong-Xue
authors.initials: HX
authors.lastname: Shi
authors.forename: Cai
authors.initials: C
authors.lastname: Lin
authors.forename: Bei-Bei
authors.initials: BB
authors.lastname: Lin
authors.forename: Zhou-Guang
authors.initials: ZG
authors.lastname: Wang
authors.forename: Hong-Yu
authors.initials: HY
authors.lastname: Zhang
authors.forename: Fen-Zan
authors.initials: FZ
authors.lastname: Wu
authors.forename: Yi
authors.initials: Y
authors.lastname: Cheng
authors.forename: Li-Jun
authors.initials: LJ
authors.lastname: Xiang
authors.forename: Di-Jiong
authors.initials: DJ
authors.lastname: Guo
authors.forename: Xu
authors.initials: X
authors.lastname: Luo
authors.forename: Guo-You
authors.initials: GY
authors.lastname: Zhang
authors.forename: Xiao-Bing
authors.initials: XB
authors.lastname: Fu
authors.forename: Saverio
authors.initials: S
authors.lastname: Bellusci
authors.forename: Xiao-Kun
authors.initials: XK
authors.lastname: Li
authors.forename: Jian
authors.initials: J
authors.lastname: Xiao
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism; D017209:Apoptosis / Q000187:drug effects; D017439:Cicatrix, Hypertrophic / Q000188:drug therapy; D024042:Collagen Type I / Q000096:biosynthesis; D024061:Collagen Type III / Q000096:biosynthesis; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D023421:Models, Animal; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects; D053773:Transforming Growth Factor beta1 / Q000378:metabolism; D014945:Wound Healing / Q000187:drug effects* / Q000502:physiology*; D000097382:CD68 Molecule
chemical_list: D000199:Actins; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D024042:Collagen Type I; D024061:Collagen Type III; D016222:Fibroblast Growth Factor 2; D018809:Proliferating Cell Nuclear Antigen; D053773:Transforming Growth Factor beta1; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C498862:Acta2 protein, rat
references.citation: J Burn Care Res. 2012 Sep-Oct;33(5):668-77
references.pmid: 22210076
references.citation: Wound Repair Regen. 2012 Sep-Oct;20(5):658-66
references.pmid: 22882499
references.citation: J Burn Care Rehabil. 1991 May-Jun;12(3):257-62
references.pmid: 1885644
references.citation: Wound Repair Regen. 2008 Sep-Oct;16(5):635-41
references.pmid: 19128258
references.citation: Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
references.pmid: 19128254
references.citation: Surgery. 2001 Nov;130(5):798-808
references.pmid: 11685189
references.citation: Wound Repair Regen. 2008 Jul-Aug;16(4):576-81
references.pmid: 18638277
references.citation: Histopathology. 2009 May;54(6):722-30
references.pmid: 19438747
references.citation: Burns. 2009 Jun;35(4):463-75
references.pmid: 18951704
references.citation: J Am Coll Surg. 2007 Jul;205(1):78-88
references.pmid: 17617336
references.citation: Plast Reconstr Surg. 1998 Nov;102(6):1962-72
references.pmid: 9810992
references.citation: Nat Rev Drug Discov. 2009 Mar;8(3):235-53
references.pmid: 19247306
references.citation: J Invest Dermatol. 2004 Dec;123(6):1176-81
references.pmid: 15610531
references.citation: Life Sci. 2008 Jan 16;82(3-4):190-204
references.pmid: 18164317
references.citation: Wound Repair Regen. 2007 Sep-Oct;15(5):617-23
references.pmid: 17971006
references.citation: Int Wound J. 2009 Dec;6(6):445-52
references.pmid: 20051096
references.citation: Plast Reconstr Surg. 2005 Oct;116(5):1387-90; discussion 1391-2
references.pmid: 16217483
references.citation: Biochem Biophys Res Commun. 1997 Nov 7;240(1):21-6
references.pmid: 9367874
references.citation: Lab Invest. 2012 Feb;92(2):214-23
references.pmid: 21946856
references.citation: PLoS Med. 2007 Sep;4(9):e234
references.pmid: 17803351
references.citation: CNS Neurosci Ther. 2013 Jan;19(1):20-9
references.pmid: 23082997
references.citation: Biol Pharm Bull. 2010;33(3):444-9
references.pmid: 20190407
references.citation: J Invest Dermatol. 2006 May;126(5):963-70
references.pmid: 16498397
references.citation: Sci Transl Med. 2011 Sep 14;3(100):100ra89
references.pmid: 21918106
references.citation: J Dermatol Sci. 2011 Dec;64(3):210-6
references.pmid: 21925842
references.citation: Lancet. 1998 Nov 21;352(9141):1661-4
references.pmid: 9853438
references.citation: Burns. 2011 Aug;37(5):886-95
references.pmid: 21377274
references.citation: Int Wound J. 2011 Jun;8(3):218-23
references.pmid: 21449929
references.citation: BMC Musculoskelet Disord. 2011 May 25;12:113
references.pmid: 21612641
references.citation: J Cell Sci. 2011 Dec 1;124(Pt 23):4039-50
references.pmid: 22159414
references.citation: J Microsc. 2012 Jan;245(1):82-9
references.pmid: 21919907
references.citation: Int Rev Cell Mol Biol. 2011;291:1-19
references.pmid: 22017972
references.citation: Int Wound J. 2009 Jun;6(3):214-24
references.pmid: 19538194
references.citation: Ann Plast Surg. 2010 Sep;65(3):321-5
references.pmid: 20733369
references.citation: J Eur Acad Dermatol Venereol. 2012 Feb;26(2):141-52
references.pmid: 21838832
references.citation: Proc Natl Acad Sci U S A. 1998 May 12;95(10):5672-7
references.pmid: 9576942
references.citation: Br J Plast Surg. 2002 Jun;55(4):275-82
references.pmid: 12160530